Walleye Capital LLC
- SEC CIK
- 0001758720
- Latest filing
- Aug 3, 2026
NKTR holding history
Nektar Therapeutics in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −12,878−100.0% | Sold out | Holders |
| Q1 2026 | 12,878 | $926.6K | <0.1% | +12,878 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −36,107−100.0% | Sold out | Holders |
| Q3 2025 | 36,107 | $2.05M | <0.1% | +36,107 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −1,273,379−100.0% | Sold out | Holders |
| Q1 2023 | 1,273,379 | $895.1K | <0.1% | +790,472+163.7% | Added | Holders |
| Q4 2022 | 482,907 | $1.09M | <0.1% | +9,156+1.9% | Added | Holders |
| Q3 2022 | 473,751 | $1.52M | <0.1% | −12,973−2.7% | Reduced | Holders |
| Q2 2022 | 486,724 | $1.85M | 0.1% | +112,024+29.9% | Added | Holders |
| Q1 2022 | 374,700 | $2.02M | 0.1% | +374,700 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −13,075−100.0% | Sold out | Holders |
| Q3 2021 | 13,075 | $235.0K | <0.1% | +13,075 | New | Holders |